Terms: = Ovarian cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN
17874 results:
1. Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
Li H; Peng Z; Zhu J; Zhao W; Huang Y; An R; Zheng H; Qu P; Wang L; Zhou Q; Wang D; Lou G; Wang J; Wang K; Kong B; Xie X; Yin R; Low J; Rozita AM; Sen LC; Meng YC; Kiong KS; Liu J; Liang Z; Lv W; Zhu Y; Hu W; Sun W; Su J; Wang Q; Zang R; Ma D; Gao Q
BMC Med; 2024 May; 22(1):199. PubMed ID: 38755585
[TBL] [Abstract] [Full Text] [Related]
2. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
[TBL] [Abstract] [Full Text] [Related]
3. Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis.
Zhang XY; Zhu BC; He M; Dong SS
J Ovarian Res; 2024 May; 17(1):102. PubMed ID: 38745302
[TBL] [Abstract] [Full Text] [Related]
4. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
Guo QY; Song JN; Chen YM; Yuan HN; Xue WS; Sun Y; Niu XL; Wang Y; Chen X
Med Oncol; 2024 May; 41(6):155. PubMed ID: 38744773
[TBL] [Abstract] [Full Text] [Related]
5. The Role of Palliative Surgery in the Management of Acute Intestinal Obstruction Secondary to Peritoneal Carcinomatosis.
Bhat BK; Yadav A; Nundy S
Chirurgia (Bucur); 2024 Apr; 119(2):218-226. PubMed ID: 38743835
[No Abstract] [Full Text] [Related]
6. FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development.
Ji J; Qian Q; Cheng W; Ye X; Jing A; Ma S; Ding Y; Ma X; Wang Y; Sun Q; Wang X; Chen Y; Zhu L; Yuan Q; Xu M; Qin J; Ma L; Yang J; Zhang M; Geng T; Wang S; Wang D; Song Y; Zhang B; Xu Y; Xu L; Liu S; Liu W; Liu B
Cell Death Dis; 2024 May; 15(5):332. PubMed ID: 38740744
[TBL] [Abstract] [Full Text] [Related]
7. Racial and Ethnic Disparities in the Incidence of Anti-NMDA Receptor Encephalitis.
Alsalek S; Schwarzmann KB; Budhathoki S; Hernandez-Lopez V; Smith JB; Li BH; Langer-Gould A
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200255. PubMed ID: 38728608
[TBL] [Abstract] [Full Text] [Related]
8. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
[TBL] [Abstract] [Full Text] [Related]
9. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
Quan C; Chen X; Wen H; Wu X; Li J
BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
[TBL] [Abstract] [Full Text] [Related]
11. Predictors of Blood Transfusion in Patients Undergoing Cytoreductive Surgeries for ovarian Malignancy.
Pearce JV; Zhao J; Randall L; Sullivan SA; Miller D; Tossas K
South Med J; 2024 May; 117(5):266-271. PubMed ID: 38701848
[TBL] [Abstract] [Full Text] [Related]
12. Unveiling the promising anticancer activity of palladium(II)-aryl complexes bearing diphosphine ligands: a structure-activity relationship analysis.
Tonon G; Mauceri M; Cavarzerani E; Piccolo R; Santo C; Demitri N; Orian L; Nogara PA; Rocha JBT; Canzonieri V; Rizzolio F; Visentin F; Scattolin T
Dalton Trans; 2024 May; 53(19):8463-8477. PubMed ID: 38686752
[TBL] [Abstract] [Full Text] [Related]
13. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
14. A Novel Non-Psychoactive Fatty Acid from a Marine Snail,
Vijayaraghavan CS; Raman LS; Surenderan S; Kaur H; Chinambedu MD; Thyagarajan SP; Gnanambal Krishnan ME
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675558
[TBL] [Abstract] [Full Text] [Related]
15. Effects of Resveratrol on In Vivo ovarian cancer Cells Implanted on the Chorioallantoic Membrane (CAM) of a Chicken Embryo Model.
Chitcholtan K; Singh M; Tino A; Garrill A; Sykes P
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673959
[TBL] [Abstract] [Full Text] [Related]
16. Synthesis of Estrone Heterodimers and Evaluation of Their In Vitro Antiproliferative Activity.
Bózsity N; Nagy V; Szabó J; Pálházi B; Kele Z; Resch V; Paragi G; Zupkó I; Minorics R; Mernyák E
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673860
[TBL] [Abstract] [Full Text] [Related]
17. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
[TBL] [Abstract] [Full Text] [Related]
18. Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.
Dhar C; Ramachandran P; Xu G; Pickering C; Čaval T; Wong M; Rice R; Zhou B; Srinivasan A; Aiyetan P; Chu CW; Moser K; Herzog TJ; Olawaiye AB; Jacob F; Serie D; Lindpaintner K; Schwarz F
Br J Cancer; 2024 Jun; 130(10):1716-1724. PubMed ID: 38658783
[TBL] [Abstract] [Full Text] [Related]
19. Mechanism of single-stranded DNA annealing by RAD52-RPA complex.
Liang CC; Greenhough LA; Masino L; Maslen S; Bajrami I; Tuppi M; Skehel M; Taylor IA; West SC
Nature; 2024 May; 629(8012):697-703. PubMed ID: 38658755
[TBL] [Abstract] [Full Text] [Related]
20. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or ovarian cancer.
Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
[TBL] [Abstract] [Full Text] [Related]
[Next]